GlycoSyn was established in 2003 to complement an existing and successful drug discovery platform with downstream process development, non-GMP and GMP manufacture of active pharmaceutical ingredients (APIs). GlycoSyn has successfully delivered development and manufacturing services to international clients involving API’s ranging in nature from flat earth small molecules to dendrimers and complex oligosaccharides.
GlycoSyn provides synthetic route evaluation and development, process development, kilogram scale non-GMP production and GMP manufacture of a variety of investigational new drugs under contract to global pharmaceutical companies. GlycoSyn has unmatched expertise in carbohydrate chemistry and multi-step chemical synthesis. Together with our partner Mimotopes we also offer custom synthesized peptide therapeutic candidates.
GlycoSyn recognises the value and confidentiality of intellectual property. This allows us to offer services under contract without claim to any discovery, improvement or gain in efficiency, realised during that contract. In short, as our client, you own and retain 100% of your valued intellectual property at all times.
From the IRL site in Lower Hutt we follow our mission.
Browse our online gallery to see more of GlycoSyn.